Solara Active Pharma Sciences Peer Comparison

Solara Active Pharma Sciences Ltd. is underperforming compared to its peers across key financial metrics, particularly in revenue growth and profitability. Companies like Sun Pharmaceutical and Cipla showcase strong growth and efficiency, making them sector leaders, while Solara's high PE ratio and negative profitability margins indicate overvaluation and financial stress.

• • Solara has the lowest revenue growth YoY and 3-Year among peers.
• • Sun Pharma leads in profitability with the highest ROE and PAT margin.
• • Solara has a significantly high PE ratio of 140.35, indicating it may be overvalued.
• • Cipla and Dr. Reddy’s are attractive due to their low PE ratios and strong returns.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth and profitability metrics in the sector.
• • Cipla Ltd.: Strong growth with a low PE ratio and high ROE.
• • Mankind Pharma Ltd.: Excellent revenue growth and profitability, coupled with a low debt ratio.